Thousands of articles have dissected the revolution we celebrate this week. Millions of words have been written about the ...

Many of the FDA’s decisions this quarter involve applications that have previously been delayed, declined or outright ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Some information you come across about COVID-19 may be out of date or false. Learn about COVID-19 myths so you can bust them when you see them.

Moderna shares rose nearly 20% after Science Day, driven partly by a short squeeze, while its mRNA pipeline beyond vaccines ...

A new comprehensive study of billions of mRNA vaccine shots confirm that they are safe and effective and that serious side effects are rare.

CNBC's Jim Cramer talks about his take on Moderna's stock performance and business outlook. Got a confidential news tip? We ...

Scientists say they have built a cell from scratch for the first time that feeds, grows and replicates like a natural cell, a ...

Anthropic launches Claude Science as big tech companies increasingly eye expansion in the wider healthcare and life sciences space.

A review of billions of mRNA vaccine doses finds strong COVID protection across groups, with rare serious side effects ...

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

The companies selling AI tools are also predicting they'll upend the workforce, and the planning implications are significant ...